RxDoctor Payments Data

Joe Bernard, MD

Neurological Surgery · Charlotte, NCNPI 1851399687

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (47.5%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Medtronic at 48.9% of the total. Reporting peaked in 2019 at $50,330 and has fallen 71.4% since, to $14,390 in 2025.

$101,448in general payments, 2019–2025

Across 177 payments — averaging $573.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$50K
  • Ischemaview, Inc.$14K
  • Stryker$14K
  • Penumbra, Inc.$12K
  • Microvention, Inc.$6K
  • Boston Scientific$2K
  • plus $3K from 23 others
$160,883in research payments, 2019–2025

Across 28 payments — averaging $5745.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$138K
  • Stryker$13K
  • Microvention, Inc.$8K
  • Viz.ai, Inc.$1K

What the payments were for

  • Royalty or licence$48,20248%
  • Consulting fees$27,35027%
  • Speaking & faculty fees$14,10014%
  • Travel & lodging$4,1324%
  • Food & beverage$7,6648%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$101,448 in reported general payments places this provider in the 85th percentile of 196 neurological surgery providers in North Carolina.

See all neurological surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$192,444
Medicare patients
277
Services billed
794

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BrilintaTicagrelor17$9,275
ClopidogrelClopidogrel Bisulfate40$335
Gabapentin28$311
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen12$116
Methylprednisolone23$115
Tizanidine Hcl15$82

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Charlotte

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →